Chronic Myeloid Leukemia
BCR-ABL-driven leukemia. Treatment with TKIs (imatinib, dasatinib, nilotinib) has transformed CML into a manageable chronic disease.
No Insights found for this cancer type.
BCR-ABL-driven leukemia. Treatment with TKIs (imatinib, dasatinib, nilotinib) has transformed CML into a manageable chronic disease.
No Insights found for this cancer type.